Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
RESEARCH TOOLSreports
Acumen Pharmaceuticals (ABOS) Ownership Overview
27.76% Insiders
11.09% Mutual Funds
41.87% Other Institutional Investors
5.96% ETFs
13.33% Public Companies and Individual Investors
The ownership structure of Acumen Pharmaceuticals (ABOS) stock is a mix of institutional, retail, and individual investors. Approximately 58.91% of the company’s stock is owned by Institutional Investors, 27.76% is owned by Insiders, and 13.33% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,932,063 | Institution | 24.85% | 21,651,491 | |
| 14,932,063 | Insider | 24.85% | 21,651,491 | |
| 1,851,797 | Institution | 3.08% | 2,685,106 | |
| 1,722,591 | Institution | 2.87% | 2,497,757 | |
| 1,618,488 | Institution | 2.69% | 2,346,808 | |
| 1,524,240 | Institution | 2.54% | 2,210,148 | |
| 1,140,000 | Institution | 1.90% | 1,653,000 | |
| 700,000 | Institution | 1.17% | 1,015,000 | |
| 667,488 | Insider | 1.11% | 967,858 | |
| 472,378 | Institution | 0.79% | 684,948 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,722,591 | Institution | 2.87% | 2,497,757 | |
| 1,618,488 | Institution | 2.69% | 2,346,808 | |
| 1,140,000 | Institution | 1.90% | 1,653,000 | |
| 700,000 | Institution | 1.17% | 1,015,000 | |
| 472,378 | Institution | 0.79% | 684,948 | |
| 317,400 | Institution | 0.53% | 460,230 | |
| 229,594 | Institution | 0.38% | 332,911 | |
| 132,000 | Institution | 0.22% | 191,400 | |
| 108,743 | Institution | 0.18% | 157,677 | |
| 56,664 | Institution | 0.09% | 82,163 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,146,316 | Institution | 1.91% | 1,971,664 | |
| 1,051,183 | Institution | 1.75% | 1,524,215 | |
| 472,172 | Institution | 0.79% | 812,136 | |
| 376,611 | Institution | 0.63% | 546,086 | |
| 199,464 | Institution | 0.33% | 343,078 | |
| 96,446 | Institution | 0.16% | 139,847 | |
| 36,448 | Institution | 0.06% | 53,214 | |
| 29,545 | Institution | 0.05% | 50,817 | |
| 23,995 | Institution | 0.04% | 35,033 | |
| 15,954 | Institution | 0.03% | 23,293 |
FAQ
Who Owns Acumen Pharmaceuticals (ABOS)?
According to the latest TipRanks data, approximately 41.87% of the company's stock is held by institutional investors, 27.76% is held by insiders, and 13.33% is held by retail investors.
What percentage of Acumen Pharmaceuticals (ABOS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 41.87% of Acumen Pharmaceuticals (ABOS) stock is held by institutional investors.
What percentage of Acumen Pharmaceuticals (ABOS) stock is held by retail investors?
According to the latest TipRanks data, approximately 13.33% of Acumen Pharmaceuticals (ABOS) stock is held by retail investors.
Who owns the most shares of Acumen Pharmaceuticals (ABOS)?
Peter Kolchinsky owns the most shares of Acumen Pharmaceuticals (ABOS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.